An experimental bispecific antibody designed to activate selected populations of T cells has produced early tumor responses in patients with advanced cancers, including some whose disease had resisted ...

A blood test could help clinicians identify patients with traumatic brain injury (TBI) who may otherwise go undiagnosed.

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

A functional map of more than 13,000 KCNQ1 variants has given researchers better understanding of those involved with long QT syndrome pathogenesis.

Microscopic traces of cancer in the bloodstream can identify patients who are high risk of their cancer returning, research suggests.

Digital twins of individual immune systems have identified a combination of two common drugs that could prevent premature birth.

An early-phase clinical study has shown that first-line firmonertinib, a tyrosine kinase inhibitor (TKI) with a unique molecular structure, has promising anti-tumor activity in patients with non-small ...

Clinical trials are generating increasingly large amounts of data, but companies are under immense pressure to complete trials quickly and under budget. Could agentic artificial intelligence (AI) be ...

Eric Easom is the co-founder and CEO of AN2 Therapeutics, a biopharmaceutical company developing small molecule therapies using its boron chemistry platform. Prior to co-founding AN2, Easom was part ...

Kiszala, the CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and repair could ...